RxDoctor Payments Data

Nishita Kothary, MD

Vascular & Interventional Radiology · Stanford, CANPI 1750437000

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,420 of the $22,979 with a category attached, or 62.8%. 15 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 45.4% of the total. Reporting peaked in 2023 at $11,007 and has fallen 62.6% since, to $4,121 in 2025.

$22,979in general payments, 2019–2025

Across 45 payments — averaging $510.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$10K
  • Cook Incorporated$4K
  • Guerbet LLC$3K
  • AstraZeneca$3K
  • Eisai Inc.$735
  • Instylla, Inc.$500
  • plus $1K from 9 others
$98,984in research payments, 2019–2025

Across 2 payments — averaging $49,492 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Varian Medical Systems, Inc.$50K
  • Siemens Medical Solutions USA, Inc.$49K

What the payments were for

  • Consulting fees$14,42063%
  • Speaking & faculty fees$4,30519%
  • Travel & lodging$1,9939%
  • Food & beverage$2,26210%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,979 in reported general payments places this provider in the 80th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California

Medicare billing

Part B allowed, 2024
$34,524
Medicare patients
93
Services billed
233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →